How Can We Help – New Indication

Your product just got approval for a new indication, but now your target market has changed. You may need to call on new specialties, inform a market that may have little to no experience with your product, or challenge your core prescribers to think of your product’s expanded use options. In any case, this is an exciting opportunity to strengthen your brand and to potentially leverage the product’s proven tolerability and convenience as prescribers build their knowledge of the product’s efficacy in the new disease state. Using moderated peer influence programs enables you to leverage existing comfort with your product to expand the market for its use. Across various specialties or within a particular specialty, peer dialogue is an effective way to drive use in the new indication.

The Peer Group has developed and perfected interactive forums that enable healthcare professionals to share clinical experiences, examine standards of care and discuss new treatment options. Various formats are available to best meet the needs of your brand: